FRPRQ
4d Pharma Plc

0
52W High
$0.212
Volume
0.00
52W Low
$0.212
Price
$0.212
Prev Close
$0.212
FRPRQ Fundamentals
50D MA
$0.212
Beta
0.00
Avg. Volume
0.00
4D is a world leader in the development of live biotherapeutics, a novel and emerging class of drugs, defined by the FDA as biological products that contain a live organism, such as a bacteria, that is applicable to the prevention, treatment or cure of a disease. 4D has developed a proprietary platform, MicroRx, that rationally identifies novel bacteria that have a precise and evolved therapeutic effect. All of 4D's live biotherapeutic products are orally delivered single strains of bacteria that are naturally found in the healthy human gut. 4D currently has a pipeline of 15 therapeutic programmes covering autoimmune diseases, CNS disorders and cancer; with two programmes in patient trials, and the expectation to initiate another three programmes over the coming twelve months.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is the 52-week high for 4d Pharma Plc?
What is the 52-week low for 4d Pharma Plc?
What is 4d Pharma Plc stock price today?
What was 4d Pharma Plc stock price yesterday?
What is the 50-day moving average of 4d Pharma Plc?

Latest FRPRQ News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.